Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation?
about
Diagnosis and management of functional symptoms in inflammatory bowel disease in remissionUpregulation of the transient receptor potential ankyrin 1 ion channel in the inflamed human and mouse colon and its protective rolesSVA retrotransposons as potential modulators of neuropeptide gene expressionDietary fiber in irritable bowel syndrome (Review)Transient receptor potential (TRP) channels: a clinical perspectiveNovel therapeutic agents in neurogastroenterology: advances in the past year.Structural and functional consequences of buserelin-induced enteric neuropathy in ratBasal Plasma Levels of Copeptin are Elevated in Inactive Inflammatory Bowel Disease after Bowel Resection.Exploration of the Esophageal Mucosal Barrier in Non-Erosive Reflux Disease.Shugan-decoction relieves visceral hyperalgesia and reduces TRPV1 and SP colon expression.Association between vasomotor rhinitis and irritable bowel syndrome.Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease.Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity.Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.The severity of inflammation at onset of ulcerative colitis is not associated with IBS-like symptoms during clinical remission.Sigmoid colon mucosal gene expression supports alterations of neuronal signaling in irritable bowel syndrome with constipation.Expression Profiling of the Transient Receptor Potential Vanilloid (TRPV) Channels 1, 2, 3 and 4 in Mucosal Epithelium of Human Ulcerative Colitis.
P2860
Q26768264-D9F772C2-9B12-4251-9618-05F0E5102A14Q27345472-5E9B05EA-1378-4644-AF83-A4C99B1CB244Q28066419-192A3B6B-BB21-4EA6-B89B-6201A1880111Q33470938-4C4C466F-5BF2-4094-A80D-EC6BF80CBFB4Q33562143-2DC23F97-6AC2-4666-88BB-D6FF53488405Q33934623-6E0304AE-2C39-4F08-ABF0-4F1D99823D7DQ34768884-198EBD6D-437C-4974-8DA7-BD66DE30EEF4Q35850091-7A424F68-B7B3-4376-B00A-E721298D69C2Q36378537-98225640-73D9-481C-9453-DB616D41C3E9Q37358662-5F832E1D-8F3B-49CC-AF5C-589C5105A0D4Q37593113-9F083DF8-DE67-445D-8FA8-40F6CB162EFBQ39176115-9989E95D-4839-4FBD-A39D-B8FA59C4B1A8Q40074896-2532EC26-C878-4333-88FF-F8E864F89A68Q40113239-DAE76659-3BC8-40F0-9528-97CBB35F9469Q40830748-DDB2EF8C-AEB1-4AE0-B0D9-4CD48496C70BQ54981845-7501F0E8-B29C-4A0F-87AE-C8CCB5C1CC57Q55515456-0DDDEFD9-6C7A-43EB-AE6D-1989A91E389E
P2860
Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation?
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Alterations in mucosal neurope ...... le in pain symptom generation?
@ast
Alterations in mucosal neurope ...... le in pain symptom generation?
@en
Alterations in mucosal neurope ...... le in pain symptom generation?
@nl
type
label
Alterations in mucosal neurope ...... le in pain symptom generation?
@ast
Alterations in mucosal neurope ...... le in pain symptom generation?
@en
Alterations in mucosal neurope ...... le in pain symptom generation?
@nl
prefLabel
Alterations in mucosal neurope ...... le in pain symptom generation?
@ast
Alterations in mucosal neurope ...... le in pain symptom generation?
@en
Alterations in mucosal neurope ...... le in pain symptom generation?
@nl
P2093
P2860
P1476
Alterations in mucosal neurope ...... le in pain symptom generation?
@en
P2093
A A Masclee
D Keszthelyi
D M Jonkers
F J Troost
J Szolcsányi
S Vanhoutvin
P2860
P304
P356
10.1002/J.1532-2149.2013.00309.X
P577
2013-03-25T00:00:00Z